Document is current
Any future updates will be listed below
-
Authors
Alqosaibi, Amany
Rasheed, Akram Husain Rehman Syed
Tombuloglu, Huseyin
Altwayan, Reham
Alhusil, Abdulrahman
Awadh, Taghreed
Ozdemir, Mehmet
- License Information
-
More Information
Article History
Received: 31 March 2026
Accepted: 5 May 2026
First Online: 16 May 2026
Declarations
:
: Reham Altwayan is currently employed by Alphagene Company (Khobar, Saudi Arabia). While Alphagene Company currently funds a separate research project on thrombophilia and genetic risk factors, it provided no financial support for the current research. This company had no role in the study’s conception, design, data collection, analysis, or the decision to publish.
: The Institutional Review Boards of Imam Abdulrahman bin Faisal University (IAU) and the King Fahad Military Medical Complex (KFMMC) approved the study under IRB protocols AFHER-IRB-2022-031 and IRB-2025-13-0660, respectively.
